ClinConnect ClinConnect Logo
Search / Trial NCT06432829

Study on the Effectiveness and Differential Usability of the UP in Spanish University Students

Launched by INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN · May 22, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Emotional Disorders University Students Unified Protocol Blended Format Online Interventions Group Formats

ClinConnect Summary

This clinical trial is studying the effectiveness of a treatment called the Unified Protocol (UP) for emotional disorders like anxiety and depression among university students in Spain. The researchers want to see how well this treatment works in two different formats: one where students meet online in a group and another that combines online learning with some in-person sessions. The goal is to find out which format is more useful and acceptable for students dealing with these issues.

To participate in the study, you need to be a student at the University of Cordoba, at least 18 years old, and have a diagnosis of anxiety or mood disorder. You should also be fluent in Spanish and have access to a device with internet, like a computer or smartphone. If you meet these criteria and choose to take part, you will be involved in treatment sessions designed to help you manage your emotions better. It’s important to note that participants who have certain severe mental health conditions or are at risk for suicide will not be eligible for this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Be enrolled at the University of Cordoba (Spain), in any of the degrees
  • Have a diagnosis of anxiety or mood disorder from the Structured Interview for Anxiety and Related Disorders, according to the DSM-5 (ADIS-5)\*
  • Be at least 18 years old
  • Be fluent in the Spanish language
  • Have a technological device (Computer, Tablet, cell phone) with internet connection
  • Have a smartphone device with Android operating system
  • In the case of taking pharmacological treatment for the treatment of their ED, maintenance of the same doses and medications for at least 3 months before starting their participation in the study and throughout the treatment
  • Signature of the informed consent
  • Exclusion Criteria:
  • Have a diagnosis of Obsessive Compulsive Disorder or Post Traumatic Stress Disorder
  • Have a severe condition that requires priority for treatment will not be able to participate in the study. This includes a serious mental disorder (personality disorder, schizophrenia, or an organic mental disorder), suicide risk at the time of assessment, or substance abuse within the past three months.

About Instituto De Investigación Sanitaria Aragón

Instituto de Investigación Sanitaria Aragón (IIS Aragón) is a leading clinical research organization dedicated to advancing healthcare through innovative research and collaboration. Based in Spain, IIS Aragón focuses on translational medicine, bridging the gap between laboratory discoveries and clinical applications. The institute fosters a multidisciplinary approach, bringing together experts from various fields to enhance the quality and efficiency of clinical trials. With a commitment to ethical standards and patient safety, IIS Aragón plays a pivotal role in driving scientific advancements and improving health outcomes in the region and beyond.

Locations

Teruel, , Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported